[Weekly Fosamax tablet is significantly more effective than risedronate daily, as results of the Head-to-Head Study show].
D019386:Alendronate / Q000008:administration & dosage*; D015519:Bone Density / Q000187:drug effects*; D004334:Drug Administration Schedule; D012968:Etidronic Acid / Q000008:administration & dosage* / Q000031:analogs & derivatives*; D005260:Female; D006801:Humans; D015337:Multicenter Studies as Topic; D015663:Osteoporosis, Postmenopausal / Q000188:drug therapy*; D016032:Randomized Controlled Trials as Topic; D000068296:Risedronic Acid; D016896:Treatment Outcome
D000068296:Risedronic Acid; D012968:Etidronic Acid; D019386:Alendronate